Fredun Pharmaceuticals (BOM:539730) Short Interest


BOM:539730 Fredun Pharmaceuticals Ltd BOM:539730
67 GF Score
Price ₹2,735.60
GF Value ₹1,576.35
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Fredun Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:539730 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fredun Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fredun Pharmaceuticals Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fredun Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Fredun Pharmaceuticals's Short Interest falls into.


BOM:539730
67GF Score
Fredun Pharmaceuticals Ltd BOM:539730
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fredun Pharmaceuticals (BOM:539730) Overvalued in 2026?

Based on GuruFocus' analysis, Fredun Pharmaceuticals stock appears to be overvalued. The current stock price of ₹2,735.60 is trading 73.5% above its estimated GF Value™ of ₹1,576.35. GuruFocus considers Fredun Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for BOM:539730:

  • Short Interest:
  • GF Value™: ₹1,576.35 vs. price of ₹2,735.60 (73.5% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the BOM:539730 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fredun Pharmaceuticals Business Description

Address Ganpatrao Kadam Marg, Delisle Road, 11th Floor, Urmi Estate 95, Lower Parel (West), Mumbai, MH, IND, 400013
Fredun Pharmaceuticals Ltd in its Endeavour to move ahead has now ventured into manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with Animal Healthcare products also with products ranging from allopathic formulations to on field diagnostic kits, Company's main objective is to be a holistic healthcare provider. The group is dedicated to improving lives of people. The Company operates only in a single segment i.e. Pharmaceutical Segment. The company has presence in Domestic as well as International market. The company generates majority of revenue from Domestic market.
67GF Score

Get the complete analysis for BOM:539730

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,735.60
Price
₹1,576.35
GF Value